Corcept Therapeutics Incorporated Earnings

The next earnings date for Corcept Therapeutics Incorporated is October 29, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Corcept Therapeutics Incorporated Earnings

Report DateEstimated Earnings Per Share
10/29/2025$0.41

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Corcept Therapeutics Incorporated Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
07/28/2025Before Market------
04/29/2025After Market$0.1718.81%
02/13/2025After Market$0.26-38.58%
10/30/2024After Market$0.4146.43%
07/29/2024After Market$0.3239.13%
05/01/2024After Market$0.2513.64%
02/15/2024After Market$0.287.69%
11/01/2023After Market$0.2827.27%
08/02/2023After Market$0.2566.67%
05/03/2023After Market$0.14-26.32%
02/28/2023After Market$0.14-39.13%
11/03/2022After Market$0.3030.43%
08/03/2022After Market$0.240.00%
05/05/2022After Market$0.20-16.67%
02/15/2022After Market$0.2618.18%
11/03/2021After Market$0.2420.00%
07/29/2021After Market$0.2131.25%
05/06/2021After Market$0.18-14.29%
02/23/2021After Market$0.205.26%
11/03/2020After Market$0.17-19.05%
08/04/2020After Market$0.234.55%
05/04/2020After Market$0.2513.64%
02/20/2020After Market$0.24-4.00%
11/07/2019After Market$0.2210.00%
08/01/2019After Market$0.17-5.56%
05/09/2019After Market$0.15-21.05%
02/25/2019After Market$0.1820.00%
11/01/2018After Market$0.14-17.65%
08/09/2018After Market$0.20-16.67%
05/08/2018After Market$0.1918.75%
02/22/2018After Market$0.17-5.56%
11/02/2017After Market$0.11-21.43%
08/01/2017After Market$0.1042.86%
05/01/2017After Market$0.0433.33%
03/06/2017Before Market$0.040.00%
11/01/2016After Market$0.02100.00%
08/02/2016After Market$0.010.00%
05/03/2016After Market$-0.00-102.00%
03/01/2016After Market$0.01200.00%
11/05/2015After Market$-0.0150.00%
08/05/2015After Market$-0.0250.00%
05/07/2015After Market$-0.05-25.00%
03/04/2015After Market$-0.0433.33%
11/04/2014After Market$-0.0614.29%
08/05/2014---$-0.0730.00%
05/07/2014---$-0.14-55.56%
03/05/2014---$-0.11-10.00%
11/07/2013---$-0.118.33%
08/08/2013---$-0.12-9.09%
05/02/2013---$-0.11-22.22%
03/07/2013---$-0.11-22.22%
10/31/2012---$-0.080.00%
08/07/2012---$-0.0918.18%
05/03/2012---$-0.13-18.18%
03/05/2012---$-0.12-33.33%
11/07/2011---$-0.0820.00%
08/08/2011---$-0.11-22.22%
05/04/2011---$-0.0910.00%
03/09/2011---$-0.100.00%
11/10/2010---$-0.100.00%
08/12/2010---$-0.090.00%
05/11/2010---$-0.10-25.00%
03/25/2010---$-0.0910.00%
11/10/2009---$-0.0910.00%
08/11/2009---$-0.109.09%
05/11/2009---$-0.11-10.00%
03/30/2009---$-0.13-18.18%
11/13/2008---$-0.118.33%
08/13/2008---$-0.0910.00%
05/12/2008---$-0.1033.33%
03/27/2008---$-0.11-10.00%
11/08/2007---$-0.090.00%
08/13/2007---$-0.0455.56%
05/09/2007---$-0.1044.44%
03/28/2007---$-0.1642.86%
11/08/2006---$-0.280.00%
08/10/2006---$-0.35-29.63%
05/09/2006---$-0.30-11.11%
03/08/2006---$-0.238.00%
11/08/2005---$-0.234.17%
08/09/2005---$-0.1840.00%
05/11/2005---$-0.2414.29%
03/03/2005---$-0.2417.24%
10/28/2004---$-0.1828.00%
08/09/2004---$-0.185.26%
05/26/2004---$-0.28---

More About Corcept Therapeutics Incorporated

Country
USA
Full Time Employees
500

Corcept Therapeutics Incorporated engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of hypercortisolism; relacorilant combined with nab-paclitaxel which is in phase III clinical trial to treat platinum-resistant ovarian tumors; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; and for treatment for prostate cancer which is in phase II clinical trial. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; and miricorilant, which is in phase IIb trial for the treatment of metabolic dysfunction-associated steatohepatitis. The company was incorporated in 1998 and is headquartered in Redwood City, California.

Corcept Therapeutics Incorporated Earnings” Can Refer to the Corcept Therapeutics Incorporated Earnings Date

Some people say “Corcept Therapeutics Incorporated earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Corcept Therapeutics Incorporated position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Corcept Therapeutics Incorporated Stock on the Earnings Date

If you own Corcept Therapeutics Incorporated stock (CORT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Corcept Therapeutics Incorporated might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Corcept Therapeutics Incorporated shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Corcept Therapeutics Incorporated Earnings

You can contact us any time if you would like to ask questions about Corcept Therapeutics Incorporated earnings or anything else related to the stock market.